We have studied ligand-dependent apoptosis via the tumor necrosis factor (TNF) receptor in hepatocytes. (1) These experiments require the addition of actinomycin D (ActD) to kill cells because TNF alone does not kill rat hepatocytes in culture. FADD/MORT1 (fas-associated death domain protein) is an intracellular protein that mediates activation of proteases called caspases which are critical to the propagation of the apoptotic signaling cascade. (2) Because of its pivotal role in the cell death pathway of multiple receptors (3), we believe that the regulation of FADD may have profound effects on the modulation of cell death. We have studied the effects of actinomycin D on FADD in primary rat hepatocyte cultures in order to elucidate the molecular pathways of cell death that may be altered or manipulated in cancer.
DISCUSSION.
The killing of rat hepatocytes by actinomycin D is associated with an increase in FADD protein in a dose-and time-dependent manner. Caspase inhibitors prevented cell death by actinomycin D without blocking the increase in FADD expression. Actinomycin D, which inhibits transcription by intercalating DNA, is a commonly used chemotherapeutic agent for Wilm's tumor, rhabdomyosarcoma, and choriocarcinoma. These results suggest that the increase in expression of FADD by actinomycin D initiates the cell death cascade by a mechanism upstream of any caspase activation that does not require Fas or TNF. The upregulation of FADD may contribute to the effects of actinomycin D as a chemotherapeutic drug.
